From: Poisonings in Poland reported to the Polish National Health Fund in the years 2009–2011
ICD-10 code | Number of fatal cases (% of column) | |||
---|---|---|---|---|
RCCTs | ICUs | other departments | all departments | |
T51.0 Ethanol | 26 (8.3%) | 79 (13.2%) | 159 (20.7%) | 264 (15.7%) |
T45.5 Anticoagulants | 0 (0%) | 14 (2.3%) | 134 (17.5%) | 148 (8.8%) |
T52.3 Glycols | 56 (17.8%) | 23 (3.8%) | 32 (4.2%) | 111 (6.6%) |
T51.1 Methanol | 34 (10.8%) | 43 (7.2%) | 23 (3.0%) | 100 (6%) |
T51.9 Alcohol, unspecified | 5 (1.6%) | 21 (3.5%) | 69 (9%) | 95 (5.7%) |
T51 Alcohol, partially coded | 1 (0.3%) | 50 (8.3%) | 37 (4.8%) | 88 (5.2%) |
T58 Carbon monoxide | 18 (5,7%) | 17 (2.8%) | 22 (2.9%) | 57 (3.4%) |
T42.4 Benzodiazepines | 16 (5.1%) | 15 (2.5%) | 25 (3.3%) | 56 (3.3%) |
T43.0 Tricyclic and tetracyclic antidepressants | 12 (3.8%) | 11 (1.8%) | 9 (1.2%) | 32 (1.9%) |
T42.6 + T42.7 Other and unspecified antiepileptic and sedative-hypnotic drugs | 6 (1.9%) | 9 (1.5%) | 16 (2.1%) | 31 (1.8%) |
T40.4 + T40.6 + T40.9 Other and unspecified narcotics and psychodysleptics (includes new psychoactive substancesa) | 9 (2.9%) | 17 (2.8%) | 5 (0.7%) | 31 (1.8%) |
T43.3 Phenothiazine antipsychotics and neuroleptics | 2 (0.6%) | 20 (3.3%) | 7 (0.9%) | 29 (1.7%) |
T51.8 Other alcohols | 17 (5.4%) | 13 (2.2%) | 11 (1.4%) | 28 (1.7%) |
T47.5 Anticoagulant antagonists, vitamin K and other coagulants | 0 (0%) | 5 (0.8%) | 23 (3.0%) | 28 (1.7%) |
T46.1 Calcium channel blockers | 12 (3.8%) | 7 (1.2%) | 6 (0.8%) | 25 (1.5%) |
T60.0 + T60.3 + T60.9 Pesticides | 14 (4.5%) | 10 (1.7%) | 0 (0%) | 24 (1.4%) |
T38.3 Insulin and oral hypoglycemic (antidiabetic) drugs | 4 (1.3%) | 10 (1.7%) | 7 (0.9%) | 21 (1.3%) |
T62.0 Mushroom ingestion | 10 (3.2%) | 7 (1.2%) | 2 (0.3%) | 19 (1.1%) |
T43.8 Other psychotropic drugs | 1 (0.3%) | 10 (1.7%) | 5 (0,7%) | 16 (1.0%) |
T39.1 4-Aminophenol derivatives (includes acetaminophena) | 7 (2.5%) | 5 (0.8%) | 3 (0.4%) | 15 (0.9%) |
T43.5 Other and unspecified antipsychotics and neuroleptics | 1 (0.3%) | 6 (1.0%) | 8 (1.0%) | 15 (0.9%) |
T42.1 Iminostilbenes (includes carbamazepinea) | 8 (2.5%) | 5 (0.8%) | 0 (0%) | 13 (0.8%) |
T45.1 Antineoplastic and immunosuppressive drugs | 0 (0%) | 0 (0%) | 13 (1.7%) | 13 |
T43.2 Other and unspecified antidepressants | 3 (1.0%) | 5 (0.8%) | 3 (0.4%) | 11 (0.7%) |
T46.9 Other and unspecified agents primarily affecting the cardiovascular system | 1 (0.3%) | 5 (0.8%) | 5 (0.7%) | 11 (0.7%) |
T44.7 Beta-adrenoreceptor antagonists | 1 (0,3%) | 5 (0.8%) | 4 (0.5%) | 10 (0.6%) |
Other | 50 (15.9%) | 187 (31.2%) | 139 (18.1%) | 389 (23.2%) |
All fatal cases (T36-T65) | 314 (100%) | 599 (100%) | 767 (100%) | 1680 (100%) |